Remove Drug Development Remove Pharmaceutical Companies Remove Research Laboratories
article thumbnail

Teva appoints Eric Hughes as head of R&D and Chief Medical Officer

European Pharmaceutical Review

Dr Eric Hughes joins Teva with experience in all phases of drug development at global pharmaceutical companies, most recently Boston-based Vertex Pharmaceuticals, which he joined last year. He will be based out of Teva’s US headquarters in Parsippany, New Jersey. .

article thumbnail

Pharmaceutical microbiology: key developments 2022

European Pharmaceutical Review

” Tony Cundell: Contract manufacturing organisations (CROs), start-up companies, established pharmaceutical companies and regulatory agencies are having difficulty recruiting and retaining technically-trained personnel. He consults in the areas of microbial risk assessment, regulatory affairs and microbiological testing.

Vaccines 128
article thumbnail

Cerba Research and Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture

Pharmaceutical Technology

The formal signing ceremony of the MoU today at Cerba Research’s Ghent office was led by Mario Papillon, CEO of Cerba Research, and Xu Yi, CEO of Teddy Lab, on behalf of their respective organisations. About Teddy Clinical Research Laboratory : As a joint venture company established in 2016 by Dian Diagnostics (300244.SZ)